REVISION THERAPEUTICS

ReVision Therapeutics, Inc.

Application Filed: 2023-05-17
Trademark Application Details
Trademark Logo REVISION THERAPEUTICS

Mark For: REVISION THERAPEUTICS™ trademark registration is intended to cover the categories of pharmaceuticals for the treatment of ophthalmic diseases; medicated and non-medicated eye drops; pharmaceutical preparations, serums and injectables for the treatment of retinal or choroidal disease. [all]

Status

2023-06-07 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number98000952
Mark Literal ElementsREVISION THERAPEUTICS
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationNEW APPLICATION PROCESSING 2023-05-20
Basis1(a)
Class StatusACTIVE
Primary US Classes
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseYes
Current UseYes
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameBrian O'Donnell
Attorney Docket Number121805-0002

Timeline

2022-12-21Date of First Use
2022-12-21Date of Use In Commerce
2023-05-17Application Filed
2023-05-20Location: NEW APPLICATION PROCESSING
2023-05-20Status: Live/Pending
2023-05-20Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information.
2023-05-20Transaction Date

Trademark Parties (Applicants & Owners)

Party: ReVision Therapeutics, Inc.
Address251 Little Falls Drive Wilmington, DELAWARE UNITED STATES 19808
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

Application2023-05-17
Drawing2023-05-17
Specimen2023-05-17

Attorney of Record

BRIAN O'DONNELL
MORGAN, LEWIS & BOCKIUS LLP
1111 PENNSYLVANIA AVENUE, NW
WASHINGTON, DC 20004

Good, Services, and Codes


IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceuticals for the treatment of ophthalmic diseases; medicated and non-medicated eye drops; pharmaceutical preparations, serums and injectables for the treatment of retinal or choroidal disease. FIRST USE: 20221221. FIRST USE IN COMMERCE: 20221221

International Codes:5
U.S. Codes:005,006,018,044,046,051,052
Type CodeType
GS0051Pharmaceuticals for the treatment of ophthalmic diseases; medicated and non-medicated eye drops; pharmaceutical preparations, serums and injectables for the treatment of retinal or choroidal disease

Trademark Filing History

DescriptionDateProceeding Number
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2023-05-23
NEW APPLICATION ENTERED2023-05-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed